Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-06

Clinical Trial Update: Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma [Phase 1]

View source ↗

Summary

This entry describes a Phase 1 trial of regorafenib with conventional chemotherapy for newly diagnosed multimetastatic Ewing sarcoma. The study is currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stivarga (regorafenib)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Ewing Sarcoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING